Showing results (661-670 of 706) with videos related to
Sort By:
Pageof 71
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2011
Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in miceAime T Franco, Roberta Malaguarnera, Samuel Refetoff, et al.Molecules (Basel, Switzerland)|August 27, 2013
Sinulariolide induced hepatocellular carcinoma apoptosis through activation of mitochondrial-related apoptotic and PERK/eIF2α/ATF4/CHOP pathwayYi-Jen Chen, Jui-Hsin Su, Chia-Yu Tsao, et al.European Journal of Medicinal Chemistry|August 24, 2022
Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agentsZean Zhao, Jin Liu, Lin Yuan, et al.The Journal of Clinical Investigation|November 23, 2011
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activationDebyani Chakravarty, Elmer Santos, Mabel Ryder, et al.Bioorganic Chemistry|February 8, 2023
Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activityZean Zhao, Jian Luo, Hui Liao, et al.The Lancet. Oncology|December 15, 2015
Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based studyStephen W Duffy, Amanda Dibden, Dimitrios Michalopoulos, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 4, 2026
CD96 as a Therapeutic Target for CAR T-Cell Therapy in Acute Myeloid LeukemiaXiaotong Gao, Hailing Liu, Guokun Li, et al.Journal of Medicinal Chemistry|March 14, 2024
Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable DruggabilityXiaoyu Shi, Tong Zhao, Shuo Wang, et al.American Journal of Physiology. Endocrinology and Metabolism|May 9, 2013
Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathwaysDaniel F Vatner, Dirk Weismann, Sara A Beddow, et al.Calcified Tissue International|September 10, 2023
Associations Between Aldosterone-Renin-Ratio and Bone Parameters Derived from Peripheral Quantitative Computed Tomography and Impact Microindentation in MenKara L Holloway-Kew, Kara B Anderson, Pamela Rufus-Membere, et al.Pageof 71